AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,420,000 | -93.4% | 175,000 | -93.0% | 0.39% | -88.1% |
| Q3 2020 | $36,609,000 | +80.7% | 2,485,327 | +148.5% | 3.29% | +86.7% |
| Q4 2019 | $20,260,000 | +176.0% | 1,000,000 | 0.0% | 1.76% | +21.0% |
| Q1 2017 | $7,340,000 | +2.1% | 1,000,000 | -59.3% | 1.46% | -29.2% |
| Q2 2016 | $7,192,000 | +0.1% | 2,457,144 | 0.0% | 2.06% | -20.2% |
| Q1 2016 | $7,187,000 | +16.7% | 2,457,144 | 0.0% | 2.58% | -0.2% |
| Q4 2015 | $6,160,000 | -10.9% | 2,457,144 | 0.0% | 2.58% | -5.5% |
| Q3 2015 | $6,917,000 | +19.0% | 2,457,144 | +26.6% | 2.74% | +20.7% |
| Q2 2015 | $5,812,000 | -31.7% | 1,941,144 | 0.0% | 2.27% | -39.5% |
| Q1 2015 | $8,511,000 | -4.2% | 1,941,144 | -21.9% | 3.75% | -12.4% |
| Q4 2014 | $8,883,000 | +12.2% | 2,485,576 | +0.5% | 4.28% | +25.8% |
| Q3 2014 | $7,917,000 | – | 2,474,076 | – | 3.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |